Unknown

Dataset Information

0

Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease.


ABSTRACT: Circulating tumor DNA (ctDNA) refers to tumor-derived cell-free DNA that circulates in body fluids. Fluid samples are easier to collect than tumor tissue, and are amenable to serial collection at multiple time points during the course of a patient's illness. Studies have demonstrated the feasibility of performing mutation profiling from blood samples in cancer patients. However, detection of ctDNA in the blood of patients with brain tumors is suboptimal. Cerebrospinal fluid (CSF) can be obtained via lumbar puncture or intraventricular catheter, and may be a suitable fluid to assess ctDNA in patients with brain tumors. We detected melanoma-associated mutations by droplet-digital PCR (ddPCR) and next-generation sequencing in ctDNA obtained from the CSF (CSF-ctDNA) of melanoma patients with leptomeningeal disease. There is a strong correlation between mutation detection by ddPCR, the presence of circulating tumor cells in CSF and abnormalities in the MRI. However, approximately 30% of CSF samples that were negative or indeterminate for the presence of tumor cells by microscopic examination were positive for CSF-ctDNA by ddPCR. Our results demonstrate that CSF is a suitable fluid for evaluating ctDNA and ddPCR is superior to CSF-cytology for analysis of CSF in melanoma patients with leptomeningeal disease.

SUBMITTER: Ballester LY 

PROVIDER: S-EPMC6005029 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease.

Ballester Leomar Y LY   Glitza Oliva Isabella C IC   Douse Dzifa Y DY   Chen Melissa M MM   Lan Chieh C   Haydu Lauren E LE   Huse Jason T JT   Roy-Chowdhuri Sinchita S   Luthra Rajyalakshmi R   Wistuba Ignacio I II   Davies Michael A MA  

Journal of neuropathology and experimental neurology 20180701 7


Circulating tumor DNA (ctDNA) refers to tumor-derived cell-free DNA that circulates in body fluids. Fluid samples are easier to collect than tumor tissue, and are amenable to serial collection at multiple time points during the course of a patient's illness. Studies have demonstrated the feasibility of performing mutation profiling from blood samples in cancer patients. However, detection of ctDNA in the blood of patients with brain tumors is suboptimal. Cerebrospinal fluid (CSF) can be obtained  ...[more]

Similar Datasets

| S-EPMC9527526 | biostudies-literature
| S-EPMC9834711 | biostudies-literature
| S-EPMC8353541 | biostudies-literature
| S-EPMC7438284 | biostudies-literature
| S-EPMC5570249 | biostudies-literature
2020-02-25 | GSE125193 | GEO
| S-EPMC9957915 | biostudies-literature
2014-01-09 | E-GEOD-46068 | biostudies-arrayexpress
| S-EPMC8717892 | biostudies-literature
| S-EPMC9119011 | biostudies-literature